Trials / Completed
CompletedNCT04673682
A Clinical Trial to Evaluate the Pharmacokinetic Profiles and Safety of CKD-845
A Multicenter, Randomized, Single Blind, Single Dose, Crossover Study to Evaluate the Pharmacokinetic Profiles and Safety After Administration of CKD-845 in Males
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 47 (actual)
- Sponsor
- Chong Kun Dang Pharmaceutical · Industry
- Sex
- Male
- Age
- 19 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
A clinical trial to evaluate the pharmacokinetic profiles and safety of CKD-845.
Detailed description
A phase 1 clinical trial to evaluate pharmacokinetics and safety in male after administration of CKD-845 and D309.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | D309 | D309(Testosterone) 1 vial, Once, IM injection |
| DRUG | CKD-845 | CKD-845(Testosterone) 1 vial, Once, IM injection |
Timeline
- Start date
- 2020-11-16
- Primary completion
- 2022-05-17
- Completion
- 2022-06-07
- First posted
- 2020-12-17
- Last updated
- 2022-09-28
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04673682. Inclusion in this directory is not an endorsement.